Menu
Search
Home > Courses > HCV Treatment Updates from The Liver Meeting 2017: The End of the Pipeline

HCV Treatment Updates from The Liver Meeting 2017: The End of the Pipeline

HCV Treatment Updates from The Liver Meeting 2017: The End of the Pipeline
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 12/19/2017
Termination Date: 12/19/2020
Review Date: 3/26/2018
Presenter
  • Jordan J. Feld, MD, MPH, FRCP(C)
    Assistant Professor of Medicine
    University of Toronto
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Recognize the full complement of HCV therapies, now that further HCV regimens are unlikely to be developed.
  2. Be aware of key drug-drug interactions and other considerations for HIV coinfection.
  3. Appreciate the strategies for retreatment of HCV for those who fail a direct-acting antiviral regimen.
  4. Appreciate the challenges involved in HCV treatment uptake from screening through linkage to care.
Presenter Bio
Jordan Feld, MD, MPH, FRCP(C)
Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Currently, Dr. Feld is clinician-scientist based at the Toronto General Hospital, Toronto Centre for Liver Disease and the McLaughlin-Rotman Centre for Global Health.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on December 19, 2017 and will terminate December 18, 2020.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Feld (Presenter) had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research Grants from AbbVie, Gilead, Merck, Abbott, and Janssen; Consulting with AbbVie, Gilead, Merck, Contravir, and Janssen. Dr. Feld submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules